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Abstract
FTO (fat mass and obesity associated) was identified as an obesity-susceptibility gene by several independent large-scale
genome association studies. A cluster of SNPs (single nucleotide polymorphism) located in the first intron of FTO was found
to be significantly associated with obesity-related traits, such as body mass index, hip circumference, and body weight. FTO
encodes a protein with a novel C-terminal a-helical domain and an N-terminal double-strand b-helix domain which is
conserved in Fe(II) and 2-oxoglutarate-dependent oxygenase family. In vitro, FTO protein can demethylate single-stranded
DNA or RNA with a preference for 3-methylthymine or 3-methyluracil. Its physiological substrates and function, however,
remain to be defined. Here we report the generation and analysis of mice carrying a conditional deletion allele of Fto. Our
results demonstrate that Fto plays an essential role in postnatal growth. The mice lacking Fto completely display immediate
postnatal growth retardation with shorter body length, lower body weight, and lower bone mineral density than control
mice, but their body compositions are relatively normal. Consistent with the growth retardation, the Fto mutant mice have
reduced serum levels of IGF-1. Moreover, despite the ubiquitous expression of Fto, its specific deletion in the nervous
system results in similar phenotypes as the whole body deletion, indicating that Fto functions in the central nerve system to
regulate postnatal growth.
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Introduction
The mouse gene Fto was first cloned more than a decade ago as
one of the several genes deleted in the Fused toes (Ft) mutant
mouse created by insertional mutagenesis [1]. However, it did not
draw much attention until very recently when its human homolog
FTO was implicated in obesity. In 2007, several groups reported
that a cluster of SNPs (single nucleotide polymorphism) in the first
intron of FTO was highly associated with obesity-related traits and
higher obesity risk [2–4]. The association has been further
confirmed by other independent studies in different human
populations [5–15], thus rendering FTO the most likely culprit
for common forms of obesity. Subsequently, several studies
suggested those obesity-associated SNPs were correlated with
higher energy intake, increased appetite [16–21] without affecting
energy expenditure [18–20,22] or physical activity [17,22–24],
although one study also reported no association with energy intake
[24]. However, since the obesity-associated SNPs do not affect the
coding region of FTO, whether the connection to obesity works
through the function of FTO per se is still a question, since the
SNPs may exert influence on the expression of distant genes other
than FTO.
The FTO protein contains a double-stranded b-helix fold
typical of the members in the Fe(II) and 2-oxoglutarate-dependent
oxygenase family [25–27]. This enzyme family has diverse
biological functions all based on the similar chemical mechanism
[28,29]. Indeed, similar to a number of members in this family,
FTO can demethylate single-stranded nucleic acids in vitro
[25,26,30]. However, the physiological function and in vivo
substrates of FTO are not well defined.
Two Fto mutant mouse models have been reported before
[31,32]. The complete knockout mice displayed growth retarda-
tion and reduced adiposity [31]. The other mice model bearing a
missense mutation in Fto developed a lean phenotype later in life
while the linear growth remained unaffected [32]. The studies so
far seemed to connect the deficiency of FTO with protection of
obesity in mice.
Here we described the generation and characterization of two
mouse models with varying Fto deficiencies. The whole body Fto
knockout mice displayed immediate postnatal growth retardation,
with shorter body length, lower body weight, and lower bone
mineral density than control mice. However, the mutant mice had
relatively normal body composition and were still susceptible to
diet induced obesity. In another mouse model, Fto was specifically
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Fto, its specific deletion in the nervous system results in similar
growth retardation phenotypes as the whole body deletion,
suggesting that Fto functions in the brain to regulate postnatal
growth.
Results
FTO protein expression in mice
We raised antibodies in rabbit against full-length mouse FTO
protein and surveyed the expression in various mouse tissues with
immunoblotting. Consistent with the previous RT-PCR results
[26], the expression of FTO protein was detected in all of the
major mouse tissues examined, with the highest level of expression
in the brain and the lowest in the skeletal muscle (Figure 1A).
Within the brain, FTO is expressed more or less uniformly in
different anatomical structures, such as hypothalamus and
hippocampus (Figure 1B). Given the association of FTO with
human obesity, we wished to determine if the expression of FTO is
influenced by food intake. Adult male C57BL/6 mice were fasted
for 24 hrs and the FTO expression was examined in energy
metabolism-related tissues including white adipose tissue, brown
adipose tissue, liver, pancreas, hypothalamus, and skeletal muscle
(Figure 1C). However, no obvious changes in the expression of
FTO were detected. We also fed male C57BL/6 mice with high
fat diet for 17 weeks starting from 6-week-old, and the FTO
protein level did not show noticeable changes either (Figure 1D).
Thus, if Fto is regulated by food status or type, the regulation is
unlikely at the level of protein expression. Previous studies have
shown that the Fto mRNA level in the arcuate nucleus (ARC) of
the hypothalamus is reduced by fasting in mice [26], and increased
by exposure to high fat diet in rats [33]. It is possible these regional
changes cannot be detected in the Western blot of whole
hypothalamus.
Figure 1. FTO protein is ubiquitously expressed in mouse tissues and not affected by nutritional status in mice. (A) Tissues from adult
male C57BL/6 mice (except the ovary) were homogenized and immunoblotted. 20 mg total protein was loaded in each lane. (B) Expression of FTO in
different regions of the brain. (C) Western blot analysis of FTO in metabolism-related tissues from adult male C57BL/6 mice fed ad libitum or fasted for
24 hrs. (D) Western blot analysis of FTO in tissues from C57BL/6 male mice fed on normal chow or on high fat diet (60 kcal % fat) from 6-week-old for
17 weeks.
doi:10.1371/journal.pone.0014005.g001
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In order to investigate the physiological function of Fto in mice,
we generated a conditional knockout (cko) line by flanking exon 3
with two loxP sites (Figure 2A). Exon 3 encodes about 40% of the
protein. Deletion of exon 3 would result in frame-shift of the
downstream exons and early termination in translation (Figure 2B).
Germline transmission of the cko allele (Fto
cko) was obtained and
confirmed by Southern blot analysis (Figure 2C). F1 Fto
+/cko mice
were either directly bred to Meox2-Cre [34] mice to generate a
knockout allele (Fto
*D) still bearing the neo selection cassette, or
first bred to Flpase-expressing mice [35] to generate a floxed allele
(Fto
flox). Fto
+/flox mice were then crossed to Meox2-Cre mice to
generate the clean deletion of exon 3 allele (Fto
#D) (Figure 2A).
Both Fto
#D and Fto
*D were used as knockout in this study and will
be referred together as Fto
D from hereon, since there is no
phenotypic difference between Fto
#D/#D and Fto
*D/*D mice.
Homozygous knockout mice (Fto
D/D) were obtained by crossing
of heterozygous pairs, and the absence of FTO protein expression
in Fto
D/D mice was confirmed by Western blot analysis (Figure 2D).
Complete depletion of Fto in mice results in postnatal
growth retardation
Fto
D/D mice are viable, but only about 50% of them could
survive to postnatal day 10–14 (Table S1) as has been reported in
Figure 2. Generation of Fto knockout mice. (A) Strategy to generate various Fto alleles. Hind III indicates the enzyme cutting sites for Southern
blot analysis in (C). (B) Schematic representation of predicted Fto wildtype and knockout coding sequences (CDS). (C) Southern blot analysis of
wildtype and cko alleles. The genomic DNA was digested by Hind III, separated on agarose gel, blotted, and hybridized with the indicated probes as
shown in (A). (D) Western blot analysis of different tissues isolated from wildtype (+/+), heterozygous (+/D) and homozygous (D/D) mice.
doi:10.1371/journal.pone.0014005.g002
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happened within a few days after birth (Table S2). It is unclear what
causes the death at present. However, near term Fto
D/D embryos
wererecoveredattheMendelianratio(TableS3),indicatingthatFto
is not required for embryogenesis in mice and the death mostly
likely happened after the birth. Surviving Fto
D/D mice displayed
immediate growth retardation in both males and females
(Figure 3A). Within the first few days after the birth, the Fto
D/D
mice were already significantly lighter in weight comparing to their
wildtype and heterozygous littermates, and the difference increased
over time (Figure 3B). This is unlikely a result of that the mutant
pups were born smaller than normal, because there was no weight
difference among embryos of all three genotypes at E18.5
(Figure 3C). At the time of weaning, both male and female Fto
D/D
mice were about 65% the weight of wildtype and heterozygous
littermates (Figure 3D). While the male Fto
D/D mice remained
behind throughout adulthood, the females showed a trend of
catching up in weight later on (Figure 3D). Fto
D/D mice were also
significantly shorter in body length throughout lifetime (Figure 3E),
and they had much lower bone mineral density (Figure 3F).
Consistent with the growth retardation phenotype, Fto
D/D mice had
significantly lower serum levels of IGF-1 (insulin-like growth factor
1) than the controls at the time of growth spurt (Figure 3G).
Fto
D/D mice do not display a lean phenotype
To determine whether Fto-deficiency affects body fat mass, the
body compositions of 16-week-old mice fed on normal chow were
measured by DEXA (dual energy X-ray absorptiometry). Despite
the general decrease in size, Fto
D/D mice did not show a specific
reduction in fat. Among the 16-week-old males, Fto
D/D mice had
about 25% less lean mass than Fto
+/+ or Fto
+/D mice (Figure 4A)
and slightly less fat mass (statistically not significant) (Figure 4B).
When normalized to the total tissue weight (lean mass plus fat
mass) (Figure 4C), male mice of all three genotypes had similar fat
content (fat mass/total tissue mass %) (Figure 4D). On the other
hand, at the age of 16 weeks, female Fto
D/D mice had even more
fat mass on average than their wildtype and heterozygous
littermates (Figure 4B), while their lean mass were still less than
the controls (about 12% less, not as dramatic as the difference in
males) (Figure 4A). As a result, female Fto
D/D mice contained
higher proportion of fat (fat mass/total tissue mass %) than
wildtype or heterozygous mice (Figure 4D). The increased fat mass
in mutant females compensated for their slight deficit in lean mass,
and made it the total tissue mass even (Figure 4C), which also
explains the trend of catching-up in whole body weight as the mice
got older (Figure 3D).
Fto
D/D mice are susceptible to diet-induced-obesity
To determine if the status of Fto has an effect on the response to
diet, both male and female mice of three genotypes (Fto
+/+, Fto
+/D
and Fto
D/D) were fed on high fat diet (60 kcal % fat) from 4-week-old
on for 10 weeks. Unexpectedly, about half of the Fto
D/D mice on
high fat diet developed dermatitis (Figure S2A, Table S4) at the late
stage of the diet regimen, and they became very lean due to the
illness (Figure S2B). The reason of this illness is unclear. The
dermatitis-free Fto
D/D mice did respond to high fat diet and
developed DIO (diet-induced-obesity) (Figure S2B). At the end of
the diet regimen, all the mice free of dermatitis were measured by
DEXA (dual energy X-ray absorptiometry). The Fto
D/D mice still
had significantly less lean mass than wildtype and heterozygotes
(Figure 5A), while they had the similar amount of fat mass
(Figure 5B). When normalized to total tissue mass (Figure 5C), the
Fto
D/D mice had relatively higher percentage of fat mass than
controls, though not statistically significant in females (Figure 5D).
At the same time, the Fto
D/D mice on high fat diet retained other
aspects of the growth retardation phenotype, such as shorter body
length (Figure 5E) and lower bone mineral density (Figure 5F).
Fto
D/D mice have higher metabolic rates
To determine whether the deletion of Fto would affect the
metabolism in mice, the O2 consumption and CO2 production of
16,17-week-old male mice were measured using indirect calor-
iometry. As there was no phenotypic difference in wildtype and
heterozygous mice, only Fto
+/D and Fto
D/D mice were used here due
to the availability of mice at the time of experiment. When the
absolute amount of O2 consumption (VO2)a n dC O 2 production
(VCO2) were measured, Fto
D/D mice showed relatively lower rates
of O2 consumption and CO2 production than Fto
+/D mice
(Figure 6A, C), during both light and dark periods (though the
difference of VO2 during light period was not statistically
significant). When divided by lean mass (conventional normaliza-
tion), the Fto
D/D mice displayed significantly higher metabolic rates
(Figure 6B,D),possiblyduetotheirmuch-reducedleanmass.When
the data was analyzed by ANCOVA using lean mass as a covariant,
the Fto
D/D mice still showed higher O2 consumption and CO2
production rates during both light and dark period (Figure S3A–D),
suggesting the deletion of Fto increases the metabolic rate, even after
its effect on body mass has been taken into account.
While the oxygen consumption was measured, we also
measured the food intake of Fto mutant mice. In a period of
72 hours, Fto
+/D and Fto
D/D mice consumed similar amount of
food (Figure 6E). However, Fto
D/D mice appeared to have
consumed more food when the amount of food intake was
normalized to lean mass (Figure 6F).
Taken together, these data suggest that Fto affects the food
intake and energy expenditure at the same time. In its absence,
both are increased.
Neural-specific Fto knockout mice are phenotypically
similar to the complete knockout
Before we generated the Fto conditional knockout line, we had
made another genetrap mouse line (Figure S1A, B) which still had
residual expression of wildtype FTO (Figure S1C). It is interesting
that homozygous genetrap mice (Fto
gt/gt) displayed none of the
phenotypes (Figure S1D–F) of Fto
D/D mice. It is possible the
residual FTO in the peripheral tissues may be enough for its
function, considering Fto heterozygous knockout mice, as well as
humans heterozygous for the FTO loss of function mutations are
generally normal [37]. On the other hand, since there was only
minimal reduction of FTO in the brain tissues of the gene-trap
mice comparing to other tissues (Figure S1C), we reasoned that Fto
might function in the brain, To explore this possibility, we deleted
Fto in the nervous system by crossing Fto
flox allele with the Nestin-
Cre transgenic mice [38] (Figure 7A). Western blotting analysis of
Fto
flox/flox/Nestin-Cre (will be referred to as Fto
ND hereafter, N
denotes neural) mice confirmed the efficient reduction of FTO
protein in the brain, but not the peripheral tissues (Figure 7B).
These mice displayed growth retardation, similar to the complete
knockout mice (Figure 7C, D). Both male and female Fto
ND mice
had shorter body length (Figure 7E) and lower bone mineral
density (Figure 7F). Fto
ND mice also had much lower serum levels
of IGF-1 during growth spurt (Figure 7G).
Neural-specific deletion of Fto affects body composition
of mice in a similar way as the whole body knockout
Similar to the whole body knockout, the body composition of
16-week old Fto
ND mice didn’t show any deficits in fat
Fto and Postnatal Growth
PLoS ONE | www.plosone.org 4 November 2010 | Volume 5 | Issue 11 | e14005Figure 3. Complete knockout of Fto results in postnatal growth retardation. (A) Representative pictures of wildtype and Fto knockout mice
at different ages. (B) Growth curves of Fto
+/+, Fto
+/D, and Fto
D/D mice from postnatal day 1 to 7. n=16/16/14 (Fto
+/+/Fto
+/D/Fto
D/D). P-values from day 1
to 7: 0.29, 0.062, 0.011, 0.0069, 0.0007, ,0.0001, and ,0.0001. (C) Body weights of Fto
+/+, Fto
+/D and Fto
D/D embryos at E18.5. n=11/19/12 (Fto
+/+/
Fto
+/D/Fto
D/D). P=0.68. (D) Growth curves of male and female Fto
+/+, Fto
+/D and Fto
D/D mice. For each genotype (Fto
+/+/Fto
+/D/Fto
D/D), n=26/31/33
(male), n=27/37/49 (female). **P,0.01 for all the time points, except in females at 12 weeks old, P=0.024. (E) Body length of adolescent and adult
Fto and Postnatal Growth
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ND mice had similar fat mass as to the
controls, with a trend of slightly less fat mass in males, and more
in females (Figure 8A). Here the difference in the fat mass in
females was not statistically significant as in the complete
knockout (possibly due to the incomplete depletion of Fto,t h e
genetic background introduced by the Nestin-Cre transgene, or a
sampling issue of individual variance). The deficit in lean mass of
Fto
ND mice remained the same as the complete knockout
(Figure 8B). Taken together, the Fto
ND mice had less total tissue
mass than the controls (Figure 8C). When normalized to the total
tissue mass, Fto
ND mice had relatively higher fat content (fat
mass/total tissue mass %) (Figure 8D), which was more obvious
in the case of females, similar to the complete knockout mice
(Figure 4D). Thus, the general trend of body composition
(increasing fat content) in neural-specific Fto knockout is similar
to that in the complete knockout.
The metabolic parameters of neural-specific Fto
knockout mice are increased similarly as in the complete
knockout mice
The metabolic rates and food intake were also measured in
16,17-week-old male Fto
N+ and Fto
ND mice. Similarly, when the
raw VO2 and VCO2 values were compared, Fto
ND mice showed
relatively lower O2 consumption and CO2 production rate than
the control mice (Figure 9A, C), during both light and dark
periods. Again, when normalized to lean mass by the simple
division, the Fto
ND mice seemed to have relatively higher metabolic
rates (Figure 9B, D). As the set of data of neural-specific knockout
mice did not show a significant linear relationship to lean mass
within groups (Figure S3E, F), ANCOVA analyses could not be
applied here.
Fto
ND mice also had similar food consumption as of Fto
N+ mice
during a period of 72 hours (Figure 9E), and appeared to have
consumed more food when normalized to the lean mass
(Figure 9F).
Discussion
We report here the analysis of two mouse models of Fto
deficiencies. The whole body deletion of Fto resulted in postnatal
growth retardation manifested as reduced body weight and length,
lower bone mineral density and lower serum IGF-1 levels, but did
not affect fat accumulation when fed on either normal or high fat
diet. Interestingly, the deletion of Fto in the nervous system
resulted in the similar growth retardation phenotypes as the whole
Figure 4. Fto knockout mice do not display a lean phenotype. (A, B, C) Lean mass (A), fat mass (B) and total tissue mass (C) of 16-week-old
mice of each genotype. (D) Body composition (fat mass/total tissue mass %) of 16-week-old mice of each genotype. P=0.35(male), and
P,0.0001(female). In (A)–(D), all mice were fed on normal chow after weaning at 3-week-old and were 16-week-old at the time of DEXA (dual energy
X-ray absorptiometry) measurement. For each genotype (Fto
+/+/Fto
+/D/Fto
D/D), n=14/13/13 (male), 17/25/32 (female). Statistical analyses were
performed by one-way ANOVA. **P,0.01. All values are mean 6 s.e.m.
doi:10.1371/journal.pone.0014005.g004
Fto
+/+, Fto
+/D and Fto
D/D mice. For each genotype (Fto
+/+/Fto
+/D/Fto
D/D), n=12/16/17 (4-week-old male), and 11/13/15 (4-week-old female); n=14/13/
13 (16-week-old male), and 17/25/32 (16-week-old female). (F) Bone mineral density of 16-week-old Fto
+/+, Fto
+/D and Fto
D/D mice. The femur bone
mineral densities were measured by DEXA (dual energy X-ray absorptiometry). For each genotype (Fto
+/+/Fto
+/D/Fto
D/D), n=14/13/13 (male); n=17/
25/32 (female). (G) Relative serum IGF-1 levels of 4-week-old mice. The serum IGF-1 levels were measured with ELISA. For each genotype (Fto
+/+/Fto
D/D),
n=7/8(male), n=5/6 (female). P,0.0001 (male), P=0.0356 (female). Statisticalanalyseswere performed byone-wayANOVA, exceptthat unpaired t-test
was used in (G). *P,0.05, **P,0.01. All values are mean 6 s.e.m.
doi:10.1371/journal.pone.0014005.g003
Fto and Postnatal Growth
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regulate growth.
The strong growth retardation phenotype in our Fto deletion
mice is consistent with that in the previously reported knockout
mouse model generated by a slightly different strategy [31].
However, we did not observe a strong lean phenotype in our
Fto-deficient mice as reported previously [32,36]. Instead, we
detected a trend of increasing fat mass content (fat mass/total
tissue mass %) in the mutants when the mice were fed on
normal chow, especially in the females. Both male and female
knockout mice also responded well to high fat diet and
developed obesity. The male mutants were even more
susceptible to diet-induced-obesity than the controls. We did
recognize that the individual variation in body fat mass was
relatively large, even in the control groups, while the lean mass
was quite constant among individuals. This variation might
have come from both genetic and environmental factors and
likely underlie the difference with the previous reports. Still, the
absence of the specific lean pheno t y p ea n dt h el a c ko fr e s i s t a n c e
to diet-induced-obesity in our Fto knockout mice are in contrast
with the previous reports.
In the initial report of Fto-deficient mice, the mutant mice were
stated to have increased enrgy expenditure when compared to
controls, which was cited as the reason for the reduction in
adiposity in spite of the relative hyperpahgia [31]. This
explanantion was recently challenged based on the lack of statistic
Figure 5. Fto
D/D mice are susceptible to high fat diet-induced obesity. (A, B, C) Lean mass (A), fat mass (B) and total tissue mass (C) of Fto
+/+,
Fto
+/D and Fto
D/D mice on high fat diet. (D) Body composition (fat mass/total tissue mass %) of Fto
+/+, Fto
+/D and Fto
D/D mice on high fat diet.
P=0.0055 (male), P=0.1(female). (E, F) Body length (E) and femur bone mineral density (F) of Fto
+/+, Fto
+/D and Fto
D/D mice on high fat diet. In (A)–(F),
all mice were fed on 60 kcal% fat diet for 10 weeks starting from 4-week-old. DEXA measurements were performed at the end of the 10-week period.
For each genotype (Fto
+/+/Fto
+/D/Fto
D/D), n=14/14/12 (male), 11/9/8 (female). Statistical analyses were performed by one-way ANOVA. **P,0.01. All
values are mean 6 s.e.m.
doi:10.1371/journal.pone.0014005.g005
Fto and Postnatal Growth
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[39,40]. We also measured the metabolic rate (in terms of O2
consumption and CO2 production) using indirect caloriometry.
While the unnormalized O2 consumption and CO2 production
rates were decreased in Fto knockout mice, the correction for lean
mass using either direct division or ANCOVA reversed the result,
pointing to an increase of metabolic rates in the mutant mice. On
the other hand, both ours and the previous study all indicated an
increase in food intake caused by Fto deficiency [31]. A more
recent report demosntrated that manipulating the FTO levels in
the arcuate nucleus of hypothalamus in rats could affect the food
intake [33]. Thus, it appears that the status of Fto has an impact on
both the energy expenditure and food intake. In the absence of Fto,
both of the two parameters are increased. Given the trend of more
fat accumulation in our Fto knockout mice, the increase in the
energy expenditure seemed overwhelmed by the increase in food
intake.
A number of human studies suggested that the risk SNPs in FTO
associate with increases in food intake [16–21], and rejected an
effect on energy expenditure [18–20,22]. It should be noted that
the effect of those SNPs on FTO itself is still unknown. Thus, the
phenotypes of Fto knockout mice do not necessarily contradict with
the results from the human studies.
The SNPs in FTO that are associated with obesity in humans
reside in the intronic region and their effect on the function of
FTO remains elusive. The limited expression studies in humans
Figure 6. Metabolic parameters in Fto complete knockout mice. (A) Average hourly oxygen consumption of 16,17-week-old male Fto
+/D and
Fto
D/D mice during the light and dark period. P=0.1044 (light), and P=0.0098(dark). (B) Average hourly oxygen consumption divided by lean mass.
P,0.0001. (C) Average hourly carbon dioxide production of 16,17-week-old male Fto
+/D and Fto
D/D mice during the light and dark period. P=0.0463
(light), and P=0.011(dark). (D) Average hourly carbon dioxide production divided by lean mass. P,0.0001. (E) Accumulative food intake over a period
of 72 hours of 16,17-week-old male Fto
+/D and Fto
D/D mice. P=0.3015. (F) Food intake divided by lean mass. P=0.0001. The number of mice used
was 7 for each genotype. Statistical analyses were performed by unpaired t-test. **P,0.01. All values are mean 6 s.e.m.
doi:10.1371/journal.pone.0014005.g006
Fto and Postnatal Growth
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FTO mRNA expression levels in adipose tissue and skeletal
muscle [41–43]. In fact, both negative and positive correlations
have been observed [41,43], complicating the effort in decipher-
ing the effect of these SNPs on FTO expression. Recently,
heterozygous loss-of-function FTO mutations have been identified
in both lean and obese humans [37]. Moreover, patients carrying
homozygous loss-of-function mutations in FTO show severe
growth retardation and multiple malformations, but no record
of obesity [44]. Thus, the growth retardation phenotype is shared
between human and mouse when FTO is not functional,
indicating a primary function of FTO in the regulation of linear
Figure 7. Neural-specific Fto knockout mice are growth retarded. (A) The breeding scheme to generate neural-specific Fto knockout mice.
(B) Western blot analysis of different tissues of Fto
N+ and Fto
ND mice. (C) Body weights of 7-day-old Fto
N+/+, Fto
N+/D and Fto
ND/D pups. For each
genotype (Fto
N+/+/Fto
N+/D/Fto
ND/D), n=17/7/9 (male), and 14/7/8 (female). (D) Growth curves of male and female Fto
N+ and Fto
ND mice. For each
genotype (Fto
N+/Fto
ND), n=30/25(male), and 24/20(female). (E, F) Body length (E) and femur bone mineral density (F) of 16-week-old Fto
N+ and Fto
ND
mice measured by DEXA. For each genotype (Fto
N+/Fto
ND), n=19/21(male), 19/17(female). (G) Relative serum IGF-1 levels of 4-week-old Fto
N+ and
Fto
ND mice. For each genotype (Fto
N+/Fto
ND), n=6/6(male), and n=5/4(female). Statistical analyses were performed by one-way ANOVA (C) or
unpaired t-test (D–G). **P,0.01. All values are mean 6 s.e.m.
doi:10.1371/journal.pone.0014005.g007
Fto and Postnatal Growth
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further investigation.
The reduced serum IGF-1 levels and a significant decrease in
bone mineral density in both whole body and neural Fto knockout
models argue for a function of Fto in the hypothalamus-pituitary
axis. This axis controls the expression and secretion of IGF-1 by
the liver through the action of growth hormone (GH), and
produces a host of other endocrine factors involved in the
regulation of many aspects of normal physiology including mineral
metabolism in the bone [45,46]. GH deficiency is associated with
obesity in humans [47] and the loss of GH function due to a
missense mutation in mice results in disproportional increases in
body fat despite an overall reduction in body size and weight [48].
It is possible that the Fto mutant mice suffer some degrees of GH
deficiency. Determining whether or not FTO regulates GH and/
or other hormones secreted by the hypothalamus-pituitary axis
will greatly facilitate the elucidation of FTO’s physiological
function in future.
Our neural-specific knockout mice recapitulated essentially all
of the phenotypes in the complete knockout mice. This indicates
that FTO function in the brain is crucial in spite of its ubiquitous
expression. The analysis of mice with sub-regional deletion of Fto
in the brain, especially, the hypothalamus-specific deletion, will
pinpoint where exactly Fto functions.
As a member of the Fe (II) and 2-oxoglutarate (2-OG)-dependent
oxygenase superfamily [25–27], FTO belongs to the AlkB subfamily
[25–27,30]. AlkB proteins are important enzymes catalyzing the
removal of alkyl adducts from DNA in both prokaryote and
eukaryote organisms [49]. More recent biochemical analysis
suggested that FTO might be a RNA demethylase [30], and recent
structure analysis of FTO also supported its preference for single-
stranded over double-stranded nucleic acids [25]. This is more
consistent with a role of FTO in regualting gene expression (at the
posttranscriptional level) than in reparing DNA. Likewise, a role of
FTO in the regulation of gene expression is more fitting with the
phenotypes of Fto mutnat mice than a role in DNA repair. Knowing
where exactly FTO funcitons will assist greatly in the identification
of its physiological substrates. The conditonal Fto knockout mice we
have generated will be helpful in that regard.
Materials and Methods
Ethics Statement
All animal experiments were performed according to the
protocol approved by the Institutional Animal Care and Use
Committee (IACUC) of Baylor College of Medicine. The Protocol
number is AN-5002.
Western blot analysis and antibodies
For Western blot analysis, tissues were lysed in RIPA buffer and
the protein concentration was determined with Bradford method.
We raised rabbit anti-mFTO antisera and affinity-purified the
antibodies for the use in immunoblotting. Anti-a-TUBULIN
antibodies were obtained from Sigma (T 5168).
Generation of Fto conditional knockout mice
The genomic DNA of targeting mouse Fto sequence containing
exon 3 (about 9 kb) was isolated from a BAC clone (Sanger
Center, UK) by gap repair. The construction of the conditional
targeting vector was carried out via homologous recombination in
E. coli [50]. The vector was linearized and introduced into
E14Tg2a.4 ES cells. Recombinant ES clones were identified by
Southern blot analysis and used to produce chimeric mice.
The F1 Fto conditional knockout mice (Fto
+/cko) were bred with
Meox2-Cre mice (JAX 003755) expressing Cre recombinase in all
the epiblast-derived tissues to delete exon3. The progenies were
Figure 8. The body composition of Fto neural-specific knockout mice. (A) Fat mass of 16-week-old Fto
N+ and Fto
ND mice. P=0.4551(male),
0.1681(female). (B) Lean mass of 16-week-old Fto
N+ and Fto
ND mice. (C) Total tissue mass of 16-week-old Fto
N+ and Fto
ND mice. P,0.0001(male), and
P=0.0175(female). (D) Body composition (fat mass/total tissue mass %) of 16-week-old Fto
N+ and Fto
ND mice. P=0.0118(male), 0.0024(female). In (A)–
(D), for each genotype (Fto
N+/Fto
ND), n=19/21(male), 19/17(female). Statistical analyses were performed by unpaired t-test. *P,0.05, **P,0.01. All
values are mean 6 s.e.m.
doi:10.1371/journal.pone.0014005.g008
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The heterozygotes (F3 and beyond) were then intercrossed to
generate complete knockout mice.
F1 Fto
+/cko mice were also bred with mice expressing FLP1
recombinase (JAX 003946) to first delete the selection cassette
flanked by the Frt sites. The mice with one floxed Fto allele
(Fto
+/flox)w e r et h e nb r e dw i t hMeox2-Cre mice (JAX 003755)
to delete exon 3. Similarly, the progenies with one Fto knockout
allele (having no selection cassette now) were backcrossed
to C57BL/6 mice for at least thr e em o r eg e n e r a t i o n s .T h e
heterozygotes were then intercrossed to generate knockout
mice.
TogeneratebrainspecificFtodeletion,Fto
flox/floxmicewerecrossed
with Nestin-Cre mice (JAX 003771) to generate Fto
+/flox/Tg(Nes-Cre)
mice, which were then crossed to Fto
flox/flox mice to generate
Fto
N+ (Fto
flox/flox and Fto
+/flox, for control) and Fto
ND (Fto
flox/flox/Nes-Cre)
mice.
Animal experiments
Animals were housed in a specific pathogen free facility at
2262uC under a cycle of 12 hr light (7:00 am light on) and 12 hr
dark (7:00 pm light off). They have free access to water and food
(normal chow: 2920X Teklad Rodent Diet). For 24 hr fasting
experiments, the food was removed from the cages at 6:00 pm, but
Figure 9. The metabolic parameters of Fto neural-specific knockout mice. (A) Average hourly oxygen consumption of 16,17-week-old
male Fto
N+ and Fto
ND mice during the light and dark period. P=0.0105 (light), and P=0.0044 (dark). (B) Average hourly oxygen consumption divided
by lean mass. P=0.00556 (light), and P=0.0233(dark). (C) Average hourly carbon dioxide production of 16,17-week-old male Fto
N+ and Fto
ND mice
during the light and dark period. P=0.004 (light), and P=0.0196(dark). (D) Average hourly carbon dioxide production divided by lean mass.
P=0.0131(light), and P=0.0142(dark). (E) Accumulative food intake over a period of 72 hours of 16,17-week-old male Fto
N+ and Fto
ND mice.
P=0.4601. (F) Food intake divided by lean mass. In (A)–(F), the number of animals used were 7 (Fto
N+) and 9 (Fto
ND). Statistical analyses were
performed by unpaired t-test. *P,0.05, **P,0.01. All values are mean 6 s.e.m.
doi:10.1371/journal.pone.0014005.g009
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normal chow was substituted by 60 kcal% fat diet (Research Diets,
Inc. D12492).
Body composition and bone mineral density were measured
with Lunar PIXImus dual energy x-ray absorptiometry (DEXA)
densitometry following the standard protocol.
Measurement of the rates of metabolism and food
consumption
The metabolic rates of mice were measured by indirect
caloriometry using the Comprehensive Lab Animal Monitoring
System (CLAMS, Columbus Instruments). The food intake was
also monitored by the system. 16,17-week-old mice were housed
individually in the monitoring cage with free access to water and
food for 3 days for acclimatization. Then the lean mass of the mice
was measured by MRI (EchoMRI), before the animals were put
back into the monitoring cages and monitored for the next 3 days
for oxygen consumption, carbon dioxide production and food
intake.
IGF-1 ELISA
Blood was collected from 4-week-old mice by cardiac
puncturing. The sera were aliquoted and snap-frozen in liquid
nitrogen. Before ELISA, the sera were extracted by acid-ethanol
with cryo-precipitation to release IGF-1 from its binding proteins
[51]. IGF-1 ELISA was performed using commercial kits (Signosis
EA-2204, and AssayPro EMI1001-1) according to the manufac-
turers’ protocols. The results were presented as the read-out from
the microplate reader (spectrometer).
Statistic analysis
All statistic analyses were performed by one-way ANOVA
(three sample sets) or unpaired t-test (two sample sets). ANCOVA
was used when indicated.
Supporting Information
Figure S1 Generation and characterization of Fto gene-trap
mice. (A) Schematic representation of Fto gene-trap strategy. (B)
Schematic representation of predicted Fto wildtype and gene-trap
coding sequence (CDS). (C) Western blot analysis of tissues from
mice of all genotypes. (D) Growth curves of Fto
+/+ and Fto
gt/gt
mice. For each genotype (Fto
+/+/Fto
gt/gt), n=16/15 (males); 12/16
(females). All values are mean 6 s.e.m. (E) The body length of
adult Fto
+/+ and Fto
gt/gt mice. At the time of the measurement,
males were 13,14.5-week-old, and females 13,16-week-old. For
each genotype (Fto
+/+/Fto
gt/gt,), n=10/9 (males); 7/7 (females). All
values are mean 6 s.e.m. (F) Body composition (fat mass/total
tissue mass %) of Fto
+/+ and Fto
gt/gt mice fed on normal chow or
high fat diet. Body composition was measured by DEXA (dual
energy X-ray absorptiometry). For normal chow group, males
were 13,14.5-week-old, and females 13,16-week-old. For each
genotype (Fto
+/+/Fto
gt/gt,), n=10/9 (males); 7/7 (females). For the
high fat diet group, at the time of measurement, the mice had been
fed on high fat diet (60 kcal % fat) for 12 weeks from 6-week-old.
For each genotype (Fto
+/+/Fto
gt/gt,), n=11/6 (males); 8/8
(females). Statistical analyses were performed by unpaired t-test.
All values are mean 6 s.e.m.
Found at: doi:10.1371/journal.pone.0014005.s001 (0.74 MB TIF)
Figure S2 Dermatitis in Fto knockout mice after high fat diet
regimen. (A) A representative picture of an Fto
D/D mice suffering
dermatitis around the neck area. (B) A representative picture of
Fto
+/+ and Fto
D/D mice after the high fat diet. The asterisk denotes
the one with dermatitis.
Found at: doi:10.1371/journal.pone.0014005.s002 (0.74 MB TIF)
Figure S3 Metabolic rate of Fto mutant mice analyzed by
ANCOVA. (A, C) Average hourly O2 consumption (A) and
average hourly CO2 production (C) in relation to lean mass of
16,17-week-old male Fto
+/D and Fto
D/D mice during light and
dark period. (B, D) Average hourly O2 consumption (B) and
average hourly CO2 production (D) of 16,17-week-old male
Fto
+/D and Fto
D/D mice adjusted by ANCOVA using an average
lean mass. In (A)–(D), n=7/7 (Fto
+/D/Fto
D/D). In (B) and (D),
statistical analyses were performed by unpaired t-test using
adjusted data. **P,0.01. All values are mean 6 s.e.m. (E, F)
Average hourly O2 consumption (E) and CO2 production (F) in
relation to lean mass of 16,17-week-old male Fto
N+ and Fto
ND
mice during light and dark period. n=7/9 (Fto
N+/Fto
ND). No
significant linear relationship was detected.
Found at: doi:10.1371/journal.pone.0014005.s003 (0.50 MB TIF)
Table S1 Genotypes of 10,14-day-old pups from heterozygote
intercrosses.
Found at: doi:10.1371/journal.pone.0014005.s004 (0.04 MB
PDF)
Table S2 Genotypes of 1,3-day-old pups from heterozygote
intercrosses that were found dead or missing.
Found at: doi:10.1371/journal.pone.0014005.s005 (0.03 MB
PDF)
Table S3 Genotypes of E14.5,18.5 embryos from heterozygote
intercrosses.
Found at: doi:10.1371/journal.pone.0014005.s006 (0.03 MB
PDF)
Table S4 Number of mice that developed dermatitis on high fat
diet.
Found at: doi:10.1371/journal.pone.0014005.s007 (0.04 MB
PDF)
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